EUVIMEDEUVIMED entdecken
Crossref

Dasatinib and Chronic Myeloid Leukemia: Two-Year Follow-up in Eight Clinical Trials

Jirí Pavlů, David Marin

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 417-424

DOI: 10.3816/clm.2009.n.083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Jirí Pavlů und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Hammersmith Hospitals Trust, Imperial College, London W12 0NN, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicDasatinibFemaleFollow-Up StudiesHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedPrecursor Cell Lymphoblastic Leukemia-LymphomaProtein Kinase InhibitorsPyrimidinesThiazoles

Substanzen

Protein Kinase InhibitorsPyrimidinesThiazolesDasatinib

Autor:innen und Institutionen

  • Department of Haematology, Hammersmith Hospitals Trust, Imperial College, London W12 0NN, UK.

Zitieren

APA

Pavlů, J., & Marin, D. (2009). Dasatinib and Chronic Myeloid Leukemia: Two-Year Follow-up in Eight Clinical Trials. Clinical Lymphoma and Myeloma, 9(6), 417-424. https://doi.org/10.3816/clm.2009.n.083

Vancouver

Pavlů J, Marin D. Dasatinib and Chronic Myeloid Leukemia: Two-Year Follow-up in Eight Clinical Trials. Clinical Lymphoma and Myeloma. 2009;9(6):417-424. doi:10.3816/clm.2009.n.083

BibTeX
@article{Pavl2009,
  author = {Pavlů, Jirí and Marin, David},
  title = {Dasatinib and Chronic Myeloid Leukemia: Two-Year Follow-up in Eight Clinical Trials},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {417--424},
  doi = {10.3816/clm.2009.n.083}
}
Kostenlos starten →